1. Home
  2. SLRX vs SKYH Comparison

SLRX vs SKYH Comparison

Compare SLRX & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • SKYH
  • Stock Information
  • Founded
  • SLRX N/A
  • SKYH 2017
  • Country
  • SLRX United States
  • SKYH United States
  • Employees
  • SLRX N/A
  • SKYH N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • SKYH Military/Government/Technical
  • Sector
  • SLRX Health Care
  • SKYH Industrials
  • Exchange
  • SLRX Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • SLRX 1.8M
  • SKYH 325.2M
  • IPO Year
  • SLRX N/A
  • SKYH N/A
  • Fundamental
  • Price
  • SLRX $0.75
  • SKYH $10.05
  • Analyst Decision
  • SLRX
  • SKYH Strong Buy
  • Analyst Count
  • SLRX 0
  • SKYH 3
  • Target Price
  • SLRX N/A
  • SKYH $14.83
  • AVG Volume (30 Days)
  • SLRX 3.6M
  • SKYH 167.7K
  • Earning Date
  • SLRX 08-08-2025
  • SKYH 08-12-2025
  • Dividend Yield
  • SLRX N/A
  • SKYH N/A
  • EPS Growth
  • SLRX N/A
  • SKYH N/A
  • EPS
  • SLRX N/A
  • SKYH N/A
  • Revenue
  • SLRX N/A
  • SKYH $17,950,000.00
  • Revenue This Year
  • SLRX N/A
  • SKYH $122.85
  • Revenue Next Year
  • SLRX N/A
  • SKYH $45.30
  • P/E Ratio
  • SLRX N/A
  • SKYH N/A
  • Revenue Growth
  • SLRX N/A
  • SKYH 102.32
  • 52 Week Low
  • SLRX $0.45
  • SKYH $8.26
  • 52 Week High
  • SLRX $7.20
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 41.73
  • SKYH 50.36
  • Support Level
  • SLRX $0.66
  • SKYH $9.75
  • Resistance Level
  • SLRX $0.90
  • SKYH $10.56
  • Average True Range (ATR)
  • SLRX 0.12
  • SKYH 0.28
  • MACD
  • SLRX -0.03
  • SKYH 0.10
  • Stochastic Oscillator
  • SLRX 16.46
  • SKYH 60.16

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: